Abstract
Aim: Cancers of unknown primary (CUP) account for about 10% in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p
| Original language | English (US) |
|---|---|
| Pages (from-to) | 6219-6222 |
| Number of pages | 4 |
| Journal | Anticancer Research |
| Volume | 35 |
| Issue number | 11 |
| State | Published - Nov 1 2015 |
Fingerprint
Keywords
- Cancer of unknown primary
- Elderly
- MESCC
- Radiation therapy
- Survival tool
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary. / Rades, Dirk; Conde-Moreno, Antonio J.; Garcia, Raquel; Veninga, Theo; Schild, Steven E.
In: Anticancer Research, Vol. 35, No. 11, 01.11.2015, p. 6219-6222.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary
AU - Rades, Dirk
AU - Conde-Moreno, Antonio J.
AU - Garcia, Raquel
AU - Veninga, Theo
AU - Schild, Steven E.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Aim: Cancers of unknown primary (CUP) account for about 10% in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p
AB - Aim: Cancers of unknown primary (CUP) account for about 10% in elderly patients with MESCC. Immediate treatment is indicated. Personalizing treatment for MESCC requires for clear understanding of the patients' survival prognosis. In this case, a tool for estimating survival would be valuable. Patients and Methods: In 104 elderly CUP patients, nine factors were investigated: age, gender, performance score, number of affected vertebrae, ability to walk at presentation for radiotherapy, additional bone metastases, visceral metastases, time developing motor weakness, radiotherapy program. Results: In multivariate analysis, the ability to walk (p=0.011) and visceral metastases (p
KW - Cancer of unknown primary
KW - Elderly
KW - MESCC
KW - Radiation therapy
KW - Survival tool
UR - http://www.scopus.com/inward/record.url?scp=84946023770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84946023770&partnerID=8YFLogxK
M3 - Article
C2 - 26504054
AN - SCOPUS:84946023770
VL - 35
SP - 6219
EP - 6222
JO - Anticancer Research
JF - Anticancer Research
SN - 0250-7005
IS - 11
ER -